First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

526 Reviews

Credit Rating - ENDOARTEX LTD

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: ENDOARTEX LTD, THE LEGACY BUSINESS CENTRE 2A RUCKHOLT ROAD, OFFICE 228, LONDON, E10 5NP. The legal status is a Private Limited Company and the current status at the registry of companies is Active - Proposal to Strike off. The last filed accounts are dated 30 April 2016. The company was incorporated on 9 April 2014.

The accounts next due date is 31 January 2018. There are no mortgages.

The above was based on public record information as at 21 September 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 08987442
Date Incorporated: 9 April 2014
Date Latest Accounts: 30 April 2016
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: ENDOSCOPY SERVISAND SALES LTD
Registered Number: 08987442
Annual Return: 9 April 2016
Registered Office: THE LEGACY BUSINESS CENTRE 2A RUCKHOLT ROAD, OFFICE 228, LONDON, E10 5NP
SIC Code and Operations: 82990
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

ENDOARTEX LTD

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 1 October 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
15747395 ENDOAXIS LTD Active
12265698 ENDOBARS LIMITED Active - Proposal to Strike off
13193097 ENDOBIL LIMITED Active
10800364 ENDOBIOGENIC MEDICINE AND INTEGRATIVE PHYSIOLOGY (SEMIP-UK) LIMITED Active
10742696 ENDOBIOGENIC MEDICINE SOCIETY CIC Active

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd